CD22 Positive: Clinical Trials

1 trial for CD22 Positive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow CD22 Positive: new trials by email Literature Review of CD22 Positive trials Research Report on CD22 Positive

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia
ADCT-602 - Blasts 5 Percent or More of Bone Marrow Nucleated Cells, CD22 Positive
Phase 1 / Phase 2TerminatedM.D. Anderson Cancer Center372018-08-242025-12-12

Narrower conditions

Burkitt Lymphoma (1)

Broader conditions

DNA Virus Infections (1)  ·  Epstein-Barr Virus Infections (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Tumor Virus Infections (1)

Sponsors

M.D. Anderson Cancer Center (1)

Countries

United States (1)

Top investigators

Nitin Jain (1)

Results publications

PMID 35622074, PMID 38324336